CRMD Q3 2021 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38,088-59.1% YoY

Gross Profit

$12,92233.9% margin

Operating Income

-$9M-22487.2% margin

Net Income

-$9M-22498.9% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+365.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$75M

Total Liabilities

$6M

Stockholders' Equity

$69M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38,088	$93,020	-59.1%
Gross Profit	$12,922	$13,107	-1.4%
Operating Income	-$9M	-$7M	-29.7%
Net Income	-$9M	-$7M	-29.8%